Vitamin D supplementation for obesity: Potential mechanisms of action and an update of randomized controlled trials

Current Nutrition and Food Science

Volumn 10, Issue 1, 2014, Pages 29-35

  Soares, Mario J ^a   Pathak, K ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Body fat; Calcium; Fat oxidation; Insulin sensitivity; Obesity; Vitamin D; Weight loss

Indexed keywords

VITAMIN D;

ARTICLE; BODY FAT; BODY WEIGHT; FAT MASS; HEALTH STATUS; HUMAN; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

EID: 84896442250     PISSN: 15734013     EISSN: 22123881     Source Type: Journal    
DOI: 10.2174/15734013113096660011     Document Type: Article

References (44)

1. AIHW 2012. Australia's health 2012. Australia's health no. 13. Cat. no. AUS 156. Canberra: AIHW.
2. Nowson C, Margerison C. Vitamin D intake and vitamin D status of Australians. Emja. 2002; 177: 149-152.
3. Ross A, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-58.
4. Mason R, Sequeira VB, Gordon-Thomson, C. Vitamin D: the light side of sunshine. Eur J Clin Nutr 2011; 65: 986-993.
5. Soares MJ, Chan She Ping-Delfos W, Ghanbari MH. Calcium and vitamin D for obesity: a review of randomized controlled trials. Eur J Clin Nutr 2011; 65, 994-1004.
6. Onakpoya I, Perry R, Zhang J, et al. Efficacy of calcium supple-mentation for management of overweight and obesity: systematic review of randomized clinical trials. Nutr Rev 2011; 69: 335-43.
7. Soares MJ, Murhadi LL, Kurpad AV, et al. Mechanistic roles for calcium and vitamin D in the regulation of body weight. Obes Rev 2012; 13: 592-605.
8. Gonzalez JT, Rumbold PLS, Stevenson EJ. Effect of calcium in- take on fat oxidation in adults: a meta-analysis of randomized controlled trials. Obes Rev 2012; 13: 848-857.
9. Christensen R, Lorenzen JK, Svith CR, et al. Effect of calcium from dairy and dietary supplements on faecal fat excretion: a metaanalysis of randomized controlled trials. Obes Rev 2009; 10: 475-486.
10. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008; 87: 1080S-1086S.
11. Norman A. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008; 88: 491S-499S.
12. Peterlik M, Cross H. Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. Eur J Nutr 2009; 105: 1-10.
13. Soares MJ, She Ping-Delfos WC, Sherriff JL, et al. Vitamin D and parathyroid hormone in insulin resistance of abdominal obesity: cause or effect? Eur J Clin Nutr 2011; 65: 1348-1352.
14. Harris S, Dawson-Hughes B. Plasma vitamin D and 25OHD responses of young and old men to supplementation with vitamin D3. J Am Coll Nutr 2002; 21: 357-362.
15. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
16. Mason C, Xiao L, Imayama I, et al. Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr 2011; 94: 95-103.
17. Song Q, Sergeev IN. Calcium and vitamin D in obesity. Nutr Res Rev 2012; 25: 130-141.
18. Sergeev IN. 1,25-Dihydroxyvitamin D3 induces Ca2+-mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochem Biophys Res Comm 2009; 384: 18-21.
19. Sergeev IN. Novel mediators of vitamin D signaling in cancer and obesity. Immun Endoc Metab Agents Med Chem 2009; 9: 153-158.
20. Duque G, Macoritto M, Kremer R. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARy2). Exp Gerontol 2004; 39: 333-338.
21. Wong K, Szeto FL, Zhang W, et al. Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physio Endocrinol Metab 2009; 296: E820-E888.
22. Shi H, Norman AW, Okamura WH, Sen A, Zemel MB. 1a,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J 2001; 15: 2751-2753.
23. Adams J, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471-478.
24. Boon N, Hul GBJ, Sicard A, et al. The effects of increasing serum calcitriol on energy and fat metabolism and gene expression. Obesity 2006; 14: 1739-1746.
25. Teegarden D, White KM, et al. Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity 2008; 16: 1566-1572.
26. Pittas A, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. Clin Endocrinol Metab 2007; 92: 2017-2029.
27. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011; 65: 1005-1015.
28. Jadad A, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
29. Carrillo AE, Flynn MG, Pinkston C, et al. Impact of vitamin D supplementation during a resistance training intervention on body composition, muscle function, and glucose tolerance in overweight and obese adults. Clin Nutr 2013; 32: 375-381.
30. Salehpour A, Hosseinpanah F, Shidfar F, et al. A 12-week double-blind randomized clinical trial of vitamin D3 supplementation on body fat mass in healthy overweight and obese women. Nutr J 2012; 11: 78.
31. Zittermann A, Frisch S, Berthold HK, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89: 1321-1327.
32. Sneve M, Figenschau Y, Jorde R. Supplementation with cholecal-ciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 2008; 159: 675-684.
33. Ardabili, HR, Gargari, BP, Farzadi, L. Vitamin D supplementation has no effect on insulin resistance assessment in women with poly-cystic ovary syndrome and vitamin D deficiency. Nutr Res 2012; 32: 195-201.
34. Forsythe L, Livingstone MBE, Barnes MS, et al. Effect of adiposity on vitamin D status and the 25-hydroxycholecalciferol response to supplementation in healthy young and older Irish adults. Br J Nutr 2012; 107: 126-134.
35. Grimnes G, Figenschau Y, Almas B, et al. Vitamin D insulin secretion, sensitivity, and lipids results from a case-control study and a randomized controlled trial using hyperglycaemic clamp technique. Diabetes 2011; 60: 2748.
36. Peake J, Kukuljan S, Nowson CA, et al. Inflammatory cytokine responses to progressive resistance training and supplementation with fortified milk in men aged 50+ years: an 18- month randomized controlled trial. Eur J Appl Physiol 2011; 111: 3079-3088.
37. Nikooyeh B, Neyestani TR, Farvid M et al. Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 2011; 93: 764-771.
38. Von-Hurst P, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomized, placebo-controlled trial. Br J Nutr 2010; 103: 549-555.
39. Trivedi D, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003; 326: 1-6.
40. Ortega R, Aparicio A, Rodríguez-Rodríguez E, et al. Preliminary data about the influence of vitamin D status on the loss of body fat in young overweight/obese women following two types of hypoca-loric diet. Br J Nutr 2008; 100: 269-272.
41. Dong Y, Stallmann-Jorgensen IS, Pollock NK, et al. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25- hydroxyvitamin D, adiposity and arterial stiffness. J Clin Endocrinol Metab 2010; 95: 1-7.
42. Shahar D, Schwarzfuchs D, Fraser D, et al. Dairy calcium intake, serum vitamin D, and successful weight loss. Am J Clin Nutr 2010; 92: 1017-1022.
43. Soares MJ. Editorial. Calcium and vitamin D for chronic disease: a time for action. Eur J Clin Nutr 2011; 65, 985.
44. Wagner J, Wright EC, Ennis MM, et al. Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors. Clin Pharmacol Ther 2009; 86: 619-625.